Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific.

Recent Press Releases

September 19, 2014 - 6:23 a.m.
European Commission Grants Marketing Authorization for Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular LymphomaPrinter Friendly Version 

Upcoming Events

Friday, September 26, 2014 through Tuesday, September 30, 2014
European Society for Medical Oncology (ESMO)
Saturday, October 25, 2014 through Thursday, October 30, 2014
American College of Chest Physicians (CHEST)
Friday, November 7, 2014 through Tuesday, November 11, 2014
American Association for the Study of Liver Diseases (AASLD): The Liver Meeting

Most Viewed Links

Updated 09/21/14
1.SEC Filings
2.Corporate Governance
3.Stock Information
4.Annual Reports
5.Gilead Board Approves Two-for-One Stock Split
* Data collected 09/13/14 - 09/20/14

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Up 2.09 (2.01%)
Data as of 09/18/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts